​

Ligand Pharmaceuticals Ownership | Who Owns Ligand Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Ligand Pharmaceuticals Ownership Summary


Ligand Pharmaceuticals is owned by 113.76% institutional investors, 2.38% insiders. Tudor investment corp et al is the largest institutional shareholder, holding 81.78% of LGND shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.62% of its assets in Ligand Pharmaceuticals shares.

LGND Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLigand Pharmaceuticals113.76%2.38%-16.14%
SectorHealthcare Stocks 245.07%12.10%-157.17%
IndustryBiotech Stocks 380.48%11.73%-292.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tudor investment corp et al15.75M81.78%$17.70M
Blackrock2.87M16.19%$241.95M
Blackrock funding, inc. /de3.10M15.60%$980.19M
Vanguard group2.07M10.71%$392.11M
Invesco1.20M6.04%$379.83M
Janus henderson group1.01M5.12%$201.62M
Vanguard capital management870.95K4.38%$275.30M
State street826.54K4.16%$261.25M
Fmr762.83K3.84%$241.12M
Franklin resources752.04K3.78%$237.71M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Villere st denis j155.51K5.87%$49.15M
Ranger investment management257.60K5.15%$81.42M
Ashford capital management207.56K5.12%$41.44M
Private capital management166.02K4.62%$52.48M
Chicago capital553.43K4.21%$174.94M
Rice hall james & associates270.05K4.15%$85.36M
Next century growth investors198.54K3.33%$62.76M
Cardinal capital management llc /ct133.67K3.08%$11.26M
Penn capital management company100.34K2.01%$31.75M
Pembroke management40.28K2.00%$12.73M

Top Buyers

HolderShares% AssetsChange
Tudor investment corp et al15.75M0.03%15.75M
Invesco1.20M0.03%378.04K
Neuberger berman group248.35K0.05%246.89K
Sixth street partners management company193.24K0.01%193.24K
Franklin resources752.04K0.05%178.87K

Top Sellers

HolderShares% AssetsChange
Macquarie group---751.79K
Cardinal capital management llc /ct133.67K3.08%-425.56K
William blair investment management---205.69K
Knott david m jr---85.00K
Bank of montreal /can/22.32K0.00%-63.87K

New Positions

HolderShares% AssetsChangeValue
Tudor investment corp et al15.75M0.03%15.75M$17.70M
Sixth street partners management company193.24K0.01%193.24K$61.08M
Norges bank46.29K0.00%46.29K$4.96M
Context capital management46.00K0.28%46.00K$14.54M
Susquehanna advisors group44.60K0.25%44.60K$14.10M

Sold Out

HolderChange
Dv trading-1.00
Mendota financial group-1.00
Td capital management-1.00
Flagship harbor advisors-1.00
Vermillion wealth management-2.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202642315.26%22,618,4978.67%1131.02%24425.13%1161.75%
Mar 31, 2026218-38.24%8,612,118-58.08%430.39%107-40.56%69-39.47%
Dec 31, 2025275-12.97%15,606,007-23.88%800.71%137-16.97%91-8.08%
Sep 30, 202530215.71%36,213,42492.32%1881.97%16315.60%887.32%
Jun 30, 20252662.31%19,162,9152.69%991.05%14410.77%82-5.75%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.22M5.62%-220.00
Delaware Small Cap Core I655.86K3.59%-57.44K
Macquarie Small Cap Core I670.37K3.44%-14.18K
Janus Henderson US SMID Cap Growth MA596.82K3.09%596.78K
Vanguard MStar Total Stk Mkt Idx Invest607.99K3.05%2.12K
Vanguard Morn Total Stk Mkt Idx Investor605.87K3.02%8.01K
Vanguard Total Stock Mkt Idx Inv605.87K3.02%8.01K
Franklin Innovation Composite570.69K2.86%20.69K
Franklin DynaTech A550.00K2.76%-
Vanguard US Total Market Shares ETF529.85K2.75%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 10, 2026Zimmermann Martine-Sell$342.00K
Sep 03, 2026Reardon Andrew CLO & SecretarySell$513.30K
Sep 03, 2026Reardon Andrew CLO & SecretarySell$605.65K
Sep 03, 2026Reardon Andrew CLO & SecretarySell$85.20K
Sep 03, 2026Reardon Andrew CLO & SecretarySell$110.70K

Insider Transactions Trends


DateBuySell
2026 Q3-20
2026 Q2-41
2026 Q1-42
2025 Q4-18
2025 Q3-8

LGND Ownership FAQ


Who Owns Ligand Pharmaceuticals?

Ligand Pharmaceuticals shareholders are primarily institutional investors at 113.76%, followed by 2.38% insiders and -16.14% retail investors. The average institutional ownership in Ligand Pharmaceuticals's industry, Biotech Stocks , is 380.48%, which Ligand Pharmaceuticals falls below.

Who owns the most shares of Ligand Pharmaceuticals?

Ligand Pharmaceuticals’s largest shareholders are Tudor investment corp et al (15.75M shares, 81.78%), Blackrock (2.87M shares, 16.19%), and Blackrock funding, inc. /de (3.1M shares, 15.60%). Together, they hold 113.57% of Ligand Pharmaceuticals’s total shares outstanding.

Does Blackrock own Ligand Pharmaceuticals?

Yes, BlackRock owns 16.19% of Ligand Pharmaceuticals, totaling 2.87M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 241.95M$. In the last quarter, BlackRock increased its holdings by 3.23K shares, a 0.11% change.

Who is Ligand Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Villere st denis j is Ligand Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.87% of its assets in 155.51K Ligand Pharmaceuticals shares, valued at 49.15M$.

Who is the top mutual fund holder of Ligand Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Ligand Pharmaceuticals shares, with 5.62% of its total shares outstanding invested in 1.22M Ligand Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools